Home › Neoplasie del sangue › Alabama › Birmingham
Studi clinici su Neoplasie del sangue a Birmingham, AL
11 studi su Neoplasie del sangue cercano partecipanti presso sedi a Birmingham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 2
- University of Alabama Birmingham, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
In reclutamentoFase 3
- Quetzal Site 16, Birmingham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
In reclutamentoFase 1/2
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University of Alabama at Birmingham, Birmingham
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
In reclutamentoFase 3
- Children's Hospital of Alabama, Birmingham
Cognitive Training Intervention and Attitudes Towards Genetics
In reclutamento
- University of Alabama at Birmingham, Birmingham
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
In reclutamentoFase 1
- University of Alabama at Birmingham, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
In reclutamentoFase 1
- University of Alabama at Birmingham, Birmingham
Diet and Cognitive Training in Hematologic Cancer Survivors
In reclutamento
- University of Alabama at Birmingham, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
In reclutamento
- University of Alabama at Brimingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
In reclutamentoFase 1
- University of Alabama at Birmingham, Birmingham
Studi su Neoplasie del sangue in altre città
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Seattle, WA18 studi
- Baltimore, MD18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Columbus, OH13 studi
- Edison, NJ13 studi
Altri studi a Birmingham
- Cancro (tutti i tipi)31 studi
- Cancro al seno24 studi
- Cancro ovarico23 studi
- Obesità23 studi
- Cancro del polmone non a piccole cellule22 studi
- Leucemia mieloide acuta21 studi
- Mieloma multiplo18 studi
- BPCO17 studi
- Malattie cardiovascolari17 studi
- Diabete di tipo 216 studi
- Cancro dell'endometrio16 studi
- Sovrappeso16 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.